Literature DB >> 12565931

Nonbenzamidine tetrazole derivatives as factor Xa inhibitors.

Mimi L Quan1, Christopher D Ellis, Ming Y He, Ann Y Liauw, Francis J Woerner, Richard S Alexander, Robert M Knabb, Patrick Y S Lam, Joseph M Luettgen, Pancras C Wong, Matthew R Wright, Ruth R Wexler.   

Abstract

Factor Xa (fXa) is an important serine protease that holds the central position linking the intrinsic and extrinsic activation mechanisms in the blood coagulation cascade. Therefore, inhibition of fXa has potential therapeutic applications in the treatments of both arterial and venous thrombosis. Herein we describe a series of tetrazole fXa inhibitors containing benzamidine mimics as the P(1) substrate, of which the aminobenzisoxazole moiety was found to be the most potent benzamidine mimic. SR374 (12) inhibits fXa with a K(i) value of 0.35 nM and is very selective for fXa over thrombin and trypsin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12565931     DOI: 10.1016/s0960-894x(02)00951-4

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Identification of protease inhibitors by a fast fluorimetric assay.

Authors:  Nunzianna Doti; Domenico Raimondo; Marco Sabatella; Menotti Ruvo
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

Review 2.  Tetrazoles via Multicomponent Reactions.

Authors:  Constantinos G Neochoritis; Ting Zhao; Alexander Dömling
Journal:  Chem Rev       Date:  2019-02-01       Impact factor: 60.622

3.  3-(4-Bromo-phen-yl)-1-butyl-5-[1-(2-chloro-6-methyl-phen-yl)-1H-tetra-zol-5-yl]imidazolidine-2,4-dione.

Authors:  Gabriel B Hall; Federico Medda; Sue A Roberts; Christopher Hulme
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-06-15

4.  Design, synthesis and biological evaluation of 1-Aryl-5-(4-arylpiperazine-1-carbonyl)-1H-tetrazols as novel microtubule destabilizers.

Authors:  Chao Wang; Yuelin Li; Zi Liu; Zeyu Wang; Zihan Liu; Shuai Man; Yujing Zhang; Kai Bao; Yingliang Wu; Qi Guan; Daiying Zuo; Weige Zhang
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.